1. Home
  2. KREF vs TRVI Comparison

KREF vs TRVI Comparison

Compare KREF & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KREF
  • TRVI
  • Stock Information
  • Founded
  • KREF 2014
  • TRVI 2011
  • Country
  • KREF United States
  • TRVI United States
  • Employees
  • KREF N/A
  • TRVI N/A
  • Industry
  • KREF Real Estate Investment Trusts
  • TRVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • KREF Real Estate
  • TRVI Health Care
  • Exchange
  • KREF Nasdaq
  • TRVI Nasdaq
  • Market Cap
  • KREF 623.9M
  • TRVI 725.7M
  • IPO Year
  • KREF 2017
  • TRVI 2019
  • Fundamental
  • Price
  • KREF $9.49
  • TRVI $8.07
  • Analyst Decision
  • KREF Buy
  • TRVI Strong Buy
  • Analyst Count
  • KREF 7
  • TRVI 9
  • Target Price
  • KREF $12.32
  • TRVI $20.72
  • AVG Volume (30 Days)
  • KREF 504.6K
  • TRVI 2.9M
  • Earning Date
  • KREF 10-20-2025
  • TRVI 11-05-2025
  • Dividend Yield
  • KREF 10.59%
  • TRVI N/A
  • EPS Growth
  • KREF N/A
  • TRVI N/A
  • EPS
  • KREF N/A
  • TRVI N/A
  • Revenue
  • KREF $40,393,000.00
  • TRVI N/A
  • Revenue This Year
  • KREF $23.74
  • TRVI N/A
  • Revenue Next Year
  • KREF N/A
  • TRVI N/A
  • P/E Ratio
  • KREF N/A
  • TRVI N/A
  • Revenue Growth
  • KREF N/A
  • TRVI N/A
  • 52 Week Low
  • KREF $8.28
  • TRVI $2.36
  • 52 Week High
  • KREF $12.95
  • TRVI $9.92
  • Technical
  • Relative Strength Index (RSI)
  • KREF 49.57
  • TRVI 53.13
  • Support Level
  • KREF $9.76
  • TRVI $6.93
  • Resistance Level
  • KREF $9.90
  • TRVI $9.92
  • Average True Range (ATR)
  • KREF 0.15
  • TRVI 0.76
  • MACD
  • KREF -0.02
  • TRVI 0.11
  • Stochastic Oscillator
  • KREF 25.64
  • TRVI 37.96

About KREF KKR Real Estate Finance Trust Inc.

KKR Real Estate Finance Trust Inc is a real estate finance company that focuses on originating and acquiring senior mortgage loans secured by CRE assets. The investment is to originate or acquire senior mortgage loans collateralized by institutional-quality CRE assets that are owned and operated by experienced and well-capitalized sponsors and located in liquid markets with underlying fundamentals. KKR manages investments across multiple asset classes, including private equity, real estates, energy, infrastructure, credit, and hedge funds. The company's investment objective is capital preservation and generating attractive risk-adjusted returns for its stockholders over the long term, through dividends.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

Share on Social Networks: